HMGB1 promotes tumor progression and invasion through HMGB1/TNFR1/NF-κB axis in castration-resistant prostate cancer
HMGB1; NF-kappa B; Prostate cancer; TNFR1.- Am J Cancer Res
- 5.3
- 2021 May 15;11(5):2215-2227.
- Human
- 抗体芯片
- 生殖系统
- 生殖系统
- 前列腺癌
- ASC,IL-18 R alpha,RelA/p65 (pS529),BCL-10,IRAK1,c-Rel,CARD6,IRF5,SHARPIN,CD40/TNFRSF5,IRF8,SOCS-6,dAP1/BIRC2,JNK1/2,STAT1p91,dAP2/BIRC3,JNK2,STAT1 (pY701),FADD/MORT1,LTBR/TNFRSF3,STAT2,Fas/TNFRSF6/CD95,Metadherin/AEG-1,STAT2 (pY689),IκBα,MYD88,STING/TMEM173,IκBε,NFκB1,TLR2,IKK1/IKKα/CHUK,NFκB2,TNF RI/TNFRSF1A,IKK2/IKKβ,NGF R/TNFRSF16,TNF RII/TNFRSF1B,IKKυ/NEMO,P53,TRAF2,IL-1 RI,P53 (pS46),TRAIL R1/DR4,IL-17 RA,RelA/p65,TRAIL R2/DR5
相关货号
LXAH045-1
Abstract
Prostate cancer (PCa) is the most common male cancer. Most patients treated with androgen deprivation therapy progress to castration-resistant PCa. To overcome the limitations of this treatment, there is an urgent need to identify more effective treatment targets. High mobility group box 1 protein (HMGB1) is known to be associated with progression, metastasis, and poor prognosis of several solid tumors; however, its role in PCa remains unclear. Thus, we aimed to evaluate the clinical significance and biological roles and mechanism of HMGB1 in PCa. We showed that increased expression of HMGB1 correlated with increased risk of aggressive PCa, and high expression of HMGB1 was associated with poor biochemical recurrence-free survival in a Korean cohort. Additionally, the inhibition of HMGB1 expression significantly reduced cell proliferation, invasive capacity, and NF-κB signaling in vitro. Our results indicated that HMGB1 is a critical factor in the development and progression of PCa. Moreover, we found that HMGB1 directly interacts with TNFR1, and TNFR1 overexpression in HMGB1 knockdown cells reversed the effects of HMGB1 knockdown. Importantly, our results suggest that HMGB1 binding to TNFR1 promotes tumor progression by activating the NF-κB signaling pathway in PCa; therefore, the HMGB1/TNFR1/NF-κB signaling pathway could serve as a novel therapeutic target for improving PCa therapy.Keywords:HMGB1; NF-kappa B; Prostate cancer; TNFR1.
金课堂之文献解析 文献原文请点击
本网站销售的所有产品及服务均不得用于人类或动物之临床诊断或治疗,仅可用于工业或者科研等非医疗目的。